GeneTex中国官方网站
  • China
肿瘤抑制蛋白

肿瘤抑制蛋白

Tumor Suppressor Proteins

Tumor suppressor gene products, or tumor suppressor proteins, act as barriers to block cells from proceeding down the path to cancer. In contrast to the protein products of proto-oncogenes, some tumor suppressor proteins act to restrain abnormal cell proliferation. Others promote cell death pathways or function in DNA repair. While mutated proto-oncogenes behave in a dominant fashion, tumor suppressor genes are generally recessive, thus requiring that both be inactivated or otherwise compromised in order for cancers to occur. Well-described examples of tumor suppressor proteins include RB, p53, APC and CDKN2A/p14 ARF.

Highlighted Products
Citation Support KOKD Validation IP/MS Analysis Orthogonal Validation Protein Overexpression

 

Oncoproteins: Growth Factors and Receptors

p53 antibody [DO1]

p53 antibody
(GTX70214)

Rb antibody

Rb antibody
(GTX100545)

CDKN2A / p14ARF antibody

CDKN2A / p14ARF antibody (GTX129902)

BRCA1 antibody [17F8] - ChIP grade

BRCA1 antibody
(GTX70111)

BRG1 antibody [GT2712]

BRG1 antibody
(GTX633391)

SMAD2 antibody

SMAD2 antibody
(GTX111131)

 
Promotion
奔跑吧!科研-高质量抗体,让您的研究进入快车道!

奔跑吧!科研-高质量抗体,让您的研究进入快车道!

奔跑吧!科研-高质量抗体,让您的研究进入快车道!
Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Articles
五大验证策略

五大验证策略

GeneTex employs various analytic validation strategies to ensure both consistent quality and specificity.
Newsletter

GeneTex推出RAS (G12D突变体) 重组抗体 [HL10]

GeneTex的RAS(G12D突变体)重组抗体适用于IHC染色和WB。
Newsletter

「胶」你怎么做!Western blot省时小密技

Promotion
GeneTex 抗体百元试用计划 - 体验质量 试用启航

GeneTex 抗体百元试用计划 - 体验质量 试用启航

Newsletter

Clinical trials targeting alpha-synuclein protein in Parkinson’s disease

Clinical trials targeting alpha-synuclein protein in Parkinson’s disease
Newsletter

Dogs Provide Great Help to Human Cancer Research

Dogs Provide Great Help to Human Cancer Research
Newsletter
exosome PD-L1

Improving cancer immunotherapy efficacy may depend on targeting exosomes

Improving cancer immunotherapy efficacy may depend on targeting exosomes bearing the immune checkpoint protein PD-L1
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Pathways

Epithelial–mesenchymal transition (EMT) Pathway

EMT is a process whereby tightly-interacting and immotile epithelial cells acquire the phenotype of loosely-adherent and motile mesenchymal cells.
Literature
RNA 结合蛋白

单页 - RNA 结合蛋白

下载 GeneTex 最新版本的RNA结合蛋白单页
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
癌症免疫检查点

单页 - 癌症免疫检查点

下载 GeneTex 最新版本的癌症免疫检查点单页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页
Literature

海报 - 癌症信号

下载GeneTex最新版本的癌症信号海报
Literature

折页 - 癌症相关领域

下載GeneTex最新版本的癌症相关领域折页
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Literature
RNA 结合蛋白

单页 - RNA 结合蛋白

下载 GeneTex 最新版本的RNA结合蛋白单页
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
癌症免疫检查点

单页 - 癌症免疫检查点

下载 GeneTex 最新版本的癌症免疫检查点单页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页
Literature

海报 - 癌症信号

下载GeneTex最新版本的癌症信号海报
Literature

折页 - 癌症相关领域

下載GeneTex最新版本的癌症相关领域折页